Cara Therapeutics
CARA
#10367
Rank
ยฃ6.08 M
Marketcap
ยฃ3.99
Share price
-2.56%
Change (1 day)
1,784.26%
Change (1 year)

Revenue for Cara Therapeutics (CARA)

Revenue in 2024 (TTM): ยฃ5.54 Million

According to Cara Therapeutics 's latest financial reports the company's current revenue (TTM ) is ยฃ5.35 Million. a decrease over the revenue in the year 2023 that were of ยฃ16.45 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Cara Therapeutics from 2013 to 2024

Annual revenue

Year Revenue Change
2024 ยฃ5.68 M-65.44%
2023 ยฃ16.45 M-52.44%
2022 ยฃ34.6 M102.85%
2021 ยฃ17.05 M-82.79%
2020 ยฃ99.1 M553.49%
2019 ยฃ15.16 M42.92%
2018 ยฃ10.61 M1474.17%
2017 ยฃ0.67 M867.13%
2016 ยฃ0.06 M-97.28%
2015 ยฃ2.56 M25.76%
2014 ยฃ2.04 M-71.87%
2013 ยฃ7.25 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Trevena
TRVN
ยฃ0.4 M-92.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Flexion Therapeutics
FLXN
ยฃ75.3 M 1,306.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Recro Pharma
REPH
ยฃ56.52 M 955.91%๐Ÿ‡บ๐Ÿ‡ธ USA
AcelRx Pharmaceuticals
ACRX
ยฃ0.48 M-90.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
ยฃ47.09 B 879,625.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
ยฃ69.11 B 1,291,044.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
ยฃ86.75 M 1,520.62%๐Ÿ‡บ๐Ÿ‡ธ USA